Pricing and Reimbursement

The escalating expenditure on cancer treatments, particularly checkpoint inhibitors, has drawn the attention of healthcare policymakers and providers in the United States. As these...

As prescription drug costs in the United States continue to soar, affecting millions of Americans and straining Medicaid budgets, the Centers for Medicare &...

British Columbia has introduced a groundbreaking cancer control policy aiming to reimburse multi-gene panel testing and pembrolizumab therapy for patients dealing with metastatic melanoma....

Across Europe, the challenge of swiftly delivering innovative cancer therapies into the hands of patients exacerbates the stark realities of unmet medical needs within...

In a pivotal move impacting breast cancer treatment in New Zealand, Pharmac announces a shift in the funded brand of fulvestrant injection. From December...

The healthcare community is witnessing a considerable shift in how joint replacement surgeries are managed under the Comprehensive Care for Joint Replacement (CCJR) program....

New Zealand’s pharmaceutical funding agency, Pharmac, aims to enhance transparency in the assessment and funding process of medicines by updating how applications on the...

Pharmac, New Zealand's pharmaceutical management agency, regularly updates its drug and medical application processes driven by evolving healthcare needs. These updates include changes to...

The National Institute for Health and Care Excellence (NICE) recently updated its guidance to include Lorlatinib as an approved treatment for adults with advanced...

The United States Inflation Reduction Act of 2022 took a significant step by launching the Medicare Drug Price Negotiation Program. This legislative move empowers...

High-stakes decisions await the Pharmacology and Therapeutics Advisory Committee (PTAC) as they gear up for their November 2025 meeting. From addressing mounting cancer treatment...

NICE, a renowned UK organization for health and care excellence, and the Medicines and Healthcare products Regulatory Agency (MHRA) have teamed up to unleash...

In an era marked by rapid technological advancements, the healthcare sector encounters unprecedented hurdles that demand innovative approaches. As the global population expands and...

Antiemetics play a crucial role in cancer care by enhancing patients' quality of life and ensuring better treatment adherence. However, their accessibility through insurance...

The pursuit of equitable healthcare has driven significant reforms in various areas of policy, with drug pricing taking center stage in recent years. The...